Aptose Biosciences Inc. Annual report pursuant to Section 13 and 15(d)

Note 6 - Right-of-use Assets, Operating Leases (Tables)

12 Months Ended

Dec. 31, 2021

	Year ended December 31, 2021			Year ended December 31, 2020

Right-of-use assets, beginning of year	$	1,848		$	1,837
Additions to right-of-use assets		12			11
Right-of-use assets, end of year		1,860			1,848
Accumulated amortization		(1,395	)		(923	)
Right-of use assets, NBV	$	465		$	925